Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Remke

Showing results (81-90 of 184) with videos related to

Pageof 19
Sort By:
Cell Reports|April 6, 2025
PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinomaBen Zhao, Rui Fang, Hendrik Schürmann, et al.
Acta Neuropathologica|March 10, 2012
Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastomaShyamal Dilhan Weeraratne, Vladimir Amani, Natalia Teider, et al.
Redox Biology|December 24, 2021
Glutaredoxin 2 promotes SP-1-dependent CSPG4 transcription and migration of wound healing NG2 glia and glioma cells: Enzymatic TaoismChristina Wilms, Klaudia Lepka, Felix Häberlein, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 17, 2013
Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastomaMarc Remke, Esther Hering, Nicolas U Gerber, et al.
Acta Neuropathologica|June 18, 2011
Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinctPaul A Northcott, Thomas Hielscher, Adrian Dubuc, et al.
Acta Neuropathologica|December 3, 2011
Molecular subgroups of medulloblastoma: the current consensusMichael D Taylor, Paul A Northcott, Andrey Korshunov, et al.
Oncotarget|July 25, 2016
Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastomaEric W Prince, Ilango Balakrishnan, Monil Shah, et al.
Biotechnology Journal|March 25, 2022
Progenitor cells derived from gene-engineered human induced pluripotent stem cells as synthetic cancer cell alternatives for in vitro pharmacologyConstanze Uhlmann, Ann-Christin Nickel, Daniel Picard, et al.
Blood|May 2, 2009
High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment responseMarc Remke, Stefan Pfister, Corinne Kox, et al.
Acta Neuropathologica|November 8, 2011
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samplesPaul A Northcott, David J H Shih, Marc Remke, et al.
Pageof 19

Showing results (81-90 of 184) with videos related to

Sort By:
Pageof 19
Cell Reports|April 6, 2025
PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinomaBen Zhao, Rui Fang, Hendrik Schürmann, et al.
Acta Neuropathologica|March 10, 2012
Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastomaShyamal Dilhan Weeraratne, Vladimir Amani, Natalia Teider, et al.
Redox Biology|December 24, 2021
Glutaredoxin 2 promotes SP-1-dependent CSPG4 transcription and migration of wound healing NG2 glia and glioma cells: Enzymatic TaoismChristina Wilms, Klaudia Lepka, Felix Häberlein, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 17, 2013
Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastomaMarc Remke, Esther Hering, Nicolas U Gerber, et al.
Acta Neuropathologica|June 18, 2011
Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinctPaul A Northcott, Thomas Hielscher, Adrian Dubuc, et al.
Acta Neuropathologica|December 3, 2011
Molecular subgroups of medulloblastoma: the current consensusMichael D Taylor, Paul A Northcott, Andrey Korshunov, et al.
Oncotarget|July 25, 2016
Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastomaEric W Prince, Ilango Balakrishnan, Monil Shah, et al.
Biotechnology Journal|March 25, 2022
Progenitor cells derived from gene-engineered human induced pluripotent stem cells as synthetic cancer cell alternatives for in vitro pharmacologyConstanze Uhlmann, Ann-Christin Nickel, Daniel Picard, et al.
Blood|May 2, 2009
High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment responseMarc Remke, Stefan Pfister, Corinne Kox, et al.
Acta Neuropathologica|November 8, 2011
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samplesPaul A Northcott, David J H Shih, Marc Remke, et al.
Pageof 19